A Cleveland Clinic retrospective study finds DPP-4 therapy neutral, in terms of myocardial infarction and death; and its benefits in controlling glycemia while avoiding hypoglycemia and weight gain should be considered.
Cardiac Resynchronization Therapy Has Potential Benefits in Kidney Disease
Chronic kidney disease patients are less likely to receive optimal management of heart failure despite being more likely to die of cardiovascular disease. Cardiac resynchronization therapy may improve their outcomes